Faculty

Peter K. Kaiser, MD (Chair and Moderator)
Chaney Family Endowed Chair in Ophthalmology Research
Professor of Ophthalmology
Cleveland Clinic Lerner College of Medicine
Cole Eye Institute
Cleveland, Ohio

Jay S. Duker, MD
Director
New England Eye Center
Professor and Chair
Department of Ophthalmology
Tufts University School of Medicine
Boston, Massachusetts

Allen C. Ho, MD
Professor of Ophthalmology
Thomas Jefferson University School of Medicine
Director of Retina Research
Wills Eye Hospital
Philadelphia, Pennsylvania

Daniel F. Martin, MD
Chairman
Cole Eye Institute
Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology
Cleveland Clinic
Cleveland, Ohio

Purpose and Target Audience

The clinical management of retinal diseases such as age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) continues to evolve rapidly as novel therapies and new clinical trial outcomes expand and refine our practice patterns. In this educational activity, our primary goal is to clarify optimal management of these common retinal diseases in the context of data from recent clinical trials.

This educational activity is designed for retina specialists and other ophthalmologists treating patients with AMD, DME, and RVO.

Designation Statement

The University of Louisville Continuing Medical Education & Professional Development designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville and MedEdicus LLC. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Instructions & Registration

This course takes approximately 2 hours. Please read the monograph, consult any additional references if needed. Once the materials have been reviewed, you will go to http://bit.ly/retinal2014 to take a post test followed by course evaluations, after which you will be able to generate your CME certificate. If you prefer, you can also complete the post test and evaluation found at the end of this monograph and fax it to 908-462-6555.

Learning Objectives

Upon completing this educational activity, participants should be able to:

• Discuss clinical data pertaining to the management of AMD, DME, and RVO

• Evaluate the relative efficacy and safety (ocular and systemic) of anti-VEGF agents, steroids, and laser in the treatment of AMD, DME, and RVO

• Apply evidence-based approaches to individualize treatment for patients with AMD, DME, and RVO

Hardware & Software Requirements

High speed Internet connection (Broadband, Cable or DSL)
Windows 2000 or higher
256 MBs or more of RAM
Internet Explorer 6.0 higher
Windows Media Player 10.0 or higher
Adobe Acrobat 7.0 or higher
Course content compatible with Mac OS

Disclosure

As a sponsor accredited by the ACCME, the University of Louisville School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty participating in this CME activity were asked to disclose the following:

1. Names of proprietary entities producing health care goods or services—with the exemption of nonprofit or government organizations and non–health-related companies—with which they or their spouse/partner have, or have had, a relevant financial relationship within the past 12 months. For this purpose, we consider the relevant financial relationships of a spouse/partner of which they are aware to be their financial relationships.

2. Describe what they or their spouse/partner received (eg, salary, honorarium).

3. Describe their role.

4. No relevant financial relationships.

Disclosures

CME Reviewers: John Sorenson, MD, has no relevant financial relationships with any commercial interests.

Faculty: Dr Jay S. Duker is a consultant to: Alcon/Novartis Pharmaceuticals Corporation; Allergan, Inc; EMD Serono, Inc; Optos; and ThromboGenics NV. He is a contracted researcher for Carl Zeiss Meditec, Inc; and Optovue, Inc. He is a stockholder in EyeNetra; Hemera Biosciences Inc; Ophthotech Corporation; and Paloma Pharmaceuticals, Inc.

Dr Allen C. Ho is a consultant to, a scientific advisory board member of, and a contracted researcher for: Alcon, Inc; Allergan, Inc; Genentech, Inc; Janssen Pharmaceuticals, Inc/Johnson & Johnson; Ophthotech Corporation; Oraya Therapeutics, Inc; Physician Recommended Nutriceuticals; Regeneron Pharmaceuticals, Inc; Second Sight; and ThromboGenics NV. He is a consultant to, and a scientific advisory board member of: DigiSight Technologies Inc; Endo Optiks; Merck & Co, Inc; and ONL Therapeutics, LLC. He is a contracted researcher for NEI/NIH.

Dr Peter K. Kaiser is a consultant for: Alcon, Inc; Allegro Ophthalmics, LLC; ArticDx Inc; Bayer; Chengdu Kanghong Biotechnology Co, Ltd; Genentech, Inc; Novartis; Ophthotech Corporation; Oraya Therapeutics, Inc; Regeneron Pharmaceuticals, Inc; and ThromboGenics NV.

Dr Daniel F. Martin has no relevant financial relationships with any commercial interests.

Planning Committee: Dr Peter Kaiser (see above); Cynthia Tornallyay, RD, MBA, CCMEP; and Robert M. Geist IV, MD, MA, have no relevant financial relationships with any commercial interests.

University of Louisville CME & PD: The CME & PD staff and Advisory Board have nothing to disclose with the exception of Dr Douglas Coldwell: Sirtex, Inc (Speaker) and DFine, Inc (Consultant).

Medium or Combination of Media Used: Online Enduring Material Activity Method of Physician Participation: Printed and Online/Digital Monograph Estimated Time to Complete the Educational Activity: 2.0 hours

Commercial Support

This activity is supported through an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.

Special Services

If you need special accommodations due to a disability or for an alternative form of course materials, please contact us at cmepd@louisville.edu. Continuing Medical Education & Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.

Provider Contact Information

For questions about the CME activity content, please contact University of Louisville at cmepd@louisville.edu.

Privacy Policy

All information provided by course participants is confidential and will not be shared with any other parties for any reason without permission.

Copyright

©2014 MedEdicus LLC